These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1996570)

  • 41. The use of human recombinant erythropoietin in children on chronic dialysis.
    Sallay P; Reusz G
    Acta Paediatr Hung; 1992; 32(4):333-45. PubMed ID: 1304191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
    Massimetti C; Pontillo D; Feriozzi S; Costantini S; Capezzuto A; Ancarani E
    Blood Purif; 1998; 16(6):317-24. PubMed ID: 10343078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietin.
    Abdulhadi MH; Fouad-Tarazi FM; Thomas T; Bravo EL; Paganini EP
    Nephrol Dial Transplant; 1990; 5 Suppl 1():102-8. PubMed ID: 2129437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients.
    Satoh K; Masuda T; Ikeda Y; Kurokawa S; Kamata K; Kikawada R; Takamoto T; Marumo F
    Hypertension; 1990 Mar; 15(3):262-6. PubMed ID: 2303284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in sex hormones and sexual function of patients with renal failure treated with recombinant human erythropoietin.
    Suzuki H; Murakami M; Ichihara A; Saruta T
    Nihon Jinzo Gakkai Shi; 1992 Jan; 34(1):79-84. PubMed ID: 1593800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic mechanism of the elevation in blood pressure following the improvement of anemia with recombinant human erythropoietin.
    Kamata K; Marumo F; Onoyama K
    Jpn Circ J; 1991 Jul; 55(7):649-56. PubMed ID: 1880896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The after effect of r-HuEPO in treating anemic hemodialysis patients].
    Chu JQ
    Zhonghua Hu Li Za Zhi; 1994 Feb; 29(2):78-9. PubMed ID: 7788758
    [No Abstract]   [Full Text] [Related]  

  • 48. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin.
    Schaefer RM; Kokot F; Wernze H; Geiger H; Heidland A
    Clin Nephrol; 1989 Jan; 31(1):1-5. PubMed ID: 2914405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Who should receive recombinant human erythropoietin?
    Van Stone JC
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effects of r-HuEPO on platelet function and coagulation factors in hemodialysis patients].
    Kinugasa E; Nabeshima K; Niikura K; Kawabe S; Akizawa T; Kitaoka T; Koshikawa S
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1109-16. PubMed ID: 2287103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of erythropoietin treatment on urea kinetic parameters in hemodialysis patients.
    van Geelen JA; Nubé MJ; Zuurbier PA
    Clin Nephrol; 1991 Apr; 35(4):165-70. PubMed ID: 1855319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of long-term amelioration of anemia and blood pressure control on left ventricular hypertrophy in hemodialyzed patients.
    Zehnder C; Zuber M; Sulzer M; Meyer B; Straumann E; Jenzer HR; Blumberg A
    Nephron; 1992; 61(1):21-5. PubMed ID: 1388250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
    Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
    Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
    Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Haemodynamic effect of recombinant human erythropoietin on hypotensive haemodialysis patients.
    Onoyama K; Hori K; Osato S; Fujishima M
    Nephrol Dial Transplant; 1991; 6(8):562-5. PubMed ID: 1956555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
    Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A
    Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Reappearance of pica symptoms during erythropoietin treatment].
    Duclos J
    Rev Med Chil; 1992 Mar; 120(3):296-9. PubMed ID: 1342483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of human recombinant erythropoietin on anaemia, systemic haemodynamics and renal function in predialysis renal failure patients.
    Onoyama K; Kumagai H; Takeda K; Shimamatsu K; Fujishima M
    Nephrol Dial Transplant; 1989; 4(11):966-70. PubMed ID: 2516888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients.
    Akizawa T; Kinugasa E; Kitaoka T; Koshikawa S
    Nephron; 1991; 58(4):400-6. PubMed ID: 1922603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Erythropoietin, a milestone in the history of nephrology].
    Uehlinger DE; Frey FJ
    Ther Umsch; 1995 Oct; 52(10):672-7. PubMed ID: 7482378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.